nodes	percent_of_prediction	percent_of_DWPC	metapath
Valrubicin—Epirubicin—peripheral nervous system neoplasm	0.252	0.519	CrCtD
Valrubicin—Doxorubicin—peripheral nervous system neoplasm	0.233	0.481	CrCtD
Valrubicin—TOP2A—Epirubicin—peripheral nervous system neoplasm	0.0718	0.433	CbGbCtD
Valrubicin—TOP2A—Etoposide—peripheral nervous system neoplasm	0.056	0.337	CbGbCtD
Valrubicin—Idarubicin—Epirubicin—peripheral nervous system neoplasm	0.0538	0.173	CrCrCtD
Valrubicin—Daunorubicin—Epirubicin—peripheral nervous system neoplasm	0.0538	0.173	CrCrCtD
Valrubicin—Doxorubicin—Epirubicin—peripheral nervous system neoplasm	0.0538	0.173	CrCrCtD
Valrubicin—Idarubicin—Doxorubicin—peripheral nervous system neoplasm	0.0498	0.16	CrCrCtD
Valrubicin—Epirubicin—Doxorubicin—peripheral nervous system neoplasm	0.0498	0.16	CrCrCtD
Valrubicin—Daunorubicin—Doxorubicin—peripheral nervous system neoplasm	0.0498	0.16	CrCrCtD
Valrubicin—TOP2A—Doxorubicin—peripheral nervous system neoplasm	0.0382	0.23	CbGbCtD
Valrubicin—Epirubicin—AURKA—peripheral nervous system neoplasm	0.00119	0.581	CrCbGaD
Valrubicin—Doxorubicin—AURKA—peripheral nervous system neoplasm	0.000685	0.334	CrCbGaD
Valrubicin—TOP2A—Irinotecan—Topotecan—peripheral nervous system neoplasm	0.000379	0.244	CbGdCrCtD
Valrubicin—TOP2A—Vindesine—Vincristine—peripheral nervous system neoplasm	0.000225	0.145	CbGdCrCtD
Valrubicin—Urinary retention—Vincristine—peripheral nervous system neoplasm	0.000171	0.00498	CcSEcCtD
Valrubicin—Oedema peripheral—Tretinoin—peripheral nervous system neoplasm	0.000168	0.00489	CcSEcCtD
Valrubicin—Oedema peripheral—Isotretinoin—peripheral nervous system neoplasm	0.000168	0.00489	CcSEcCtD
Valrubicin—Pneumonia—Dactinomycin—peripheral nervous system neoplasm	0.000156	0.00454	CcSEcCtD
Valrubicin—Irritability—Cisplatin—peripheral nervous system neoplasm	0.000152	0.00442	CcSEcCtD
Valrubicin—Dysuria—Alitretinoin—peripheral nervous system neoplasm	0.000151	0.00439	CcSEcCtD
Valrubicin—Pollakiuria—Alitretinoin—peripheral nervous system neoplasm	0.000149	0.00434	CcSEcCtD
Valrubicin—Flatulence—Isotretinoin—peripheral nervous system neoplasm	0.000146	0.00425	CcSEcCtD
Valrubicin—Flatulence—Tretinoin—peripheral nervous system neoplasm	0.000146	0.00425	CcSEcCtD
Valrubicin—Dysuria—Vincristine—peripheral nervous system neoplasm	0.000145	0.00423	CcSEcCtD
Valrubicin—Pneumonia—Alitretinoin—peripheral nervous system neoplasm	0.000145	0.00421	CcSEcCtD
Valrubicin—Back pain—Topotecan—peripheral nervous system neoplasm	0.000145	0.00421	CcSEcCtD
Valrubicin—Back pain—Isotretinoin—peripheral nervous system neoplasm	0.000144	0.00418	CcSEcCtD
Valrubicin—Back pain—Tretinoin—peripheral nervous system neoplasm	0.000144	0.00418	CcSEcCtD
Valrubicin—TOP2A—Vinorelbine—Vincristine—peripheral nervous system neoplasm	0.000142	0.0913	CbGdCrCtD
Valrubicin—TOP2A—Teniposide—Etoposide—peripheral nervous system neoplasm	0.000142	0.0913	CbGdCrCtD
Valrubicin—TOP2A—Podofilox—Etoposide—peripheral nervous system neoplasm	0.000142	0.0913	CbGdCrCtD
Valrubicin—Urinary tract infection—Alitretinoin—peripheral nervous system neoplasm	0.00014	0.00407	CcSEcCtD
Valrubicin—Pneumonia—Vincristine—peripheral nervous system neoplasm	0.000139	0.00406	CcSEcCtD
Valrubicin—Ageusia—Epirubicin—peripheral nervous system neoplasm	0.000139	0.00404	CcSEcCtD
Valrubicin—Ill-defined disorder—Topotecan—peripheral nervous system neoplasm	0.000139	0.00404	CcSEcCtD
Valrubicin—Anaemia—Topotecan—peripheral nervous system neoplasm	0.000138	0.00402	CcSEcCtD
Valrubicin—Ill-defined disorder—Tretinoin—peripheral nervous system neoplasm	0.000138	0.00401	CcSEcCtD
Valrubicin—Ill-defined disorder—Isotretinoin—peripheral nervous system neoplasm	0.000138	0.00401	CcSEcCtD
Valrubicin—Haematuria—Alitretinoin—peripheral nervous system neoplasm	0.000137	0.00399	CcSEcCtD
Valrubicin—Anaemia—Isotretinoin—peripheral nervous system neoplasm	0.000137	0.00399	CcSEcCtD
Valrubicin—Anaemia—Tretinoin—peripheral nervous system neoplasm	0.000137	0.00399	CcSEcCtD
Valrubicin—Anaemia—Melphalan—peripheral nervous system neoplasm	0.000135	0.00394	CcSEcCtD
Valrubicin—Malaise—Topotecan—peripheral nervous system neoplasm	0.000135	0.00392	CcSEcCtD
Valrubicin—Malaise—Tretinoin—peripheral nervous system neoplasm	0.000134	0.00389	CcSEcCtD
Valrubicin—Malaise—Isotretinoin—peripheral nervous system neoplasm	0.000134	0.00389	CcSEcCtD
Valrubicin—Ageusia—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.00374	CcSEcCtD
Valrubicin—Vasodilation procedure—Epirubicin—peripheral nervous system neoplasm	0.000128	0.00373	CcSEcCtD
Valrubicin—Vasodilation—Epirubicin—peripheral nervous system neoplasm	0.000128	0.00373	CcSEcCtD
Valrubicin—Chest pain—Topotecan—peripheral nervous system neoplasm	0.000127	0.00371	CcSEcCtD
Valrubicin—Myalgia—Topotecan—peripheral nervous system neoplasm	0.000127	0.00371	CcSEcCtD
Valrubicin—Oedema peripheral—Alitretinoin—peripheral nervous system neoplasm	0.000127	0.0037	CcSEcCtD
Valrubicin—Myalgia—Isotretinoin—peripheral nervous system neoplasm	0.000126	0.00368	CcSEcCtD
Valrubicin—Chest pain—Tretinoin—peripheral nervous system neoplasm	0.000126	0.00368	CcSEcCtD
Valrubicin—Chest pain—Isotretinoin—peripheral nervous system neoplasm	0.000126	0.00368	CcSEcCtD
Valrubicin—Myalgia—Tretinoin—peripheral nervous system neoplasm	0.000126	0.00368	CcSEcCtD
Valrubicin—Discomfort—Topotecan—peripheral nervous system neoplasm	0.000126	0.00366	CcSEcCtD
Valrubicin—Discomfort—Isotretinoin—peripheral nervous system neoplasm	0.000125	0.00363	CcSEcCtD
Valrubicin—Discomfort—Tretinoin—peripheral nervous system neoplasm	0.000125	0.00363	CcSEcCtD
Valrubicin—Myalgia—Melphalan—peripheral nervous system neoplasm	0.000125	0.00363	CcSEcCtD
Valrubicin—Chest pain—Melphalan—peripheral nervous system neoplasm	0.000125	0.00363	CcSEcCtD
Valrubicin—Nocturia—Epirubicin—peripheral nervous system neoplasm	0.000121	0.00353	CcSEcCtD
Valrubicin—Vasodilation procedure—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.00345	CcSEcCtD
Valrubicin—Vasodilation—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.00345	CcSEcCtD
Valrubicin—Pneumonia—Etoposide—peripheral nervous system neoplasm	0.000113	0.00329	CcSEcCtD
Valrubicin—Ill-defined disorder—Dactinomycin—peripheral nervous system neoplasm	0.000113	0.00327	CcSEcCtD
Valrubicin—Nocturia—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.00327	CcSEcCtD
Valrubicin—Anaemia—Dactinomycin—peripheral nervous system neoplasm	0.000112	0.00326	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Topotecan—peripheral nervous system neoplasm	0.000111	0.00324	CcSEcCtD
Valrubicin—Flatulence—Alitretinoin—peripheral nervous system neoplasm	0.000111	0.00322	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Tretinoin—peripheral nervous system neoplasm	0.00011	0.00321	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Isotretinoin—peripheral nervous system neoplasm	0.00011	0.00321	CcSEcCtD
Valrubicin—Cystitis noninfective—Epirubicin—peripheral nervous system neoplasm	0.00011	0.0032	CcSEcCtD
Valrubicin—Malaise—Dactinomycin—peripheral nervous system neoplasm	0.000109	0.00318	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Melphalan—peripheral nervous system neoplasm	0.000109	0.00317	CcSEcCtD
Valrubicin—Back pain—Alitretinoin—peripheral nervous system neoplasm	0.000109	0.00316	CcSEcCtD
Valrubicin—Cystitis—Epirubicin—peripheral nervous system neoplasm	0.000109	0.00316	CcSEcCtD
Valrubicin—Blood urea increased—Epirubicin—peripheral nervous system neoplasm	0.000106	0.00309	CcSEcCtD
Valrubicin—Back pain—Vincristine—peripheral nervous system neoplasm	0.000105	0.00305	CcSEcCtD
Valrubicin—Ill-defined disorder—Alitretinoin—peripheral nervous system neoplasm	0.000104	0.00304	CcSEcCtD
Valrubicin—Anaemia—Alitretinoin—peripheral nervous system neoplasm	0.000104	0.00302	CcSEcCtD
Valrubicin—Myalgia—Dactinomycin—peripheral nervous system neoplasm	0.000103	0.003	CcSEcCtD
Valrubicin—Discomfort—Dactinomycin—peripheral nervous system neoplasm	0.000102	0.00297	CcSEcCtD
Valrubicin—Bladder pain—Epirubicin—peripheral nervous system neoplasm	0.000102	0.00296	CcSEcCtD
Valrubicin—Cystitis noninfective—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.00296	CcSEcCtD
Valrubicin—Malaise—Alitretinoin—peripheral nervous system neoplasm	0.000101	0.00295	CcSEcCtD
Valrubicin—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.000101	0.00293	CcSEcCtD
Valrubicin—Cystitis—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.00293	CcSEcCtD
Valrubicin—Anaemia—Vincristine—peripheral nervous system neoplasm	0.0001	0.00291	CcSEcCtD
Valrubicin—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	9.98e-05	0.0029	CcSEcCtD
Valrubicin—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	9.98e-05	0.0029	CcSEcCtD
Valrubicin—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	9.98e-05	0.0029	CcSEcCtD
Valrubicin—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	9.9e-05	0.00288	CcSEcCtD
Valrubicin—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	9.9e-05	0.00288	CcSEcCtD
Valrubicin—Blood urea increased—Doxorubicin—peripheral nervous system neoplasm	9.83e-05	0.00286	CcSEcCtD
Valrubicin—TOP2A—Vinblastine—Vincristine—peripheral nervous system neoplasm	9.76e-05	0.0628	CbGdCrCtD
Valrubicin—Abdominal pain—Topotecan—peripheral nervous system neoplasm	9.65e-05	0.00281	CcSEcCtD
Valrubicin—Body temperature increased—Topotecan—peripheral nervous system neoplasm	9.65e-05	0.00281	CcSEcCtD
Valrubicin—Daunorubicin—ABCB1—peripheral nervous system neoplasm	9.64e-05	0.047	CrCbGaD
Valrubicin—Chest pain—Alitretinoin—peripheral nervous system neoplasm	9.57e-05	0.00279	CcSEcCtD
Valrubicin—Myalgia—Alitretinoin—peripheral nervous system neoplasm	9.57e-05	0.00279	CcSEcCtD
Valrubicin—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	9.57e-05	0.00279	CcSEcCtD
Valrubicin—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	9.57e-05	0.00279	CcSEcCtD
Valrubicin—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	9.57e-05	0.00279	CcSEcCtD
Valrubicin—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	9.57e-05	0.00279	CcSEcCtD
Valrubicin—Discomfort—Alitretinoin—peripheral nervous system neoplasm	9.46e-05	0.00275	CcSEcCtD
Valrubicin—Flatulence—Cisplatin—peripheral nervous system neoplasm	9.44e-05	0.00275	CcSEcCtD
Valrubicin—Bladder pain—Doxorubicin—peripheral nervous system neoplasm	9.42e-05	0.00274	CcSEcCtD
Valrubicin—Myalgia—Vincristine—peripheral nervous system neoplasm	9.23e-05	0.00268	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	9.02e-05	0.00262	CcSEcCtD
Valrubicin—Ill-defined disorder—Cisplatin—peripheral nervous system neoplasm	8.89e-05	0.00259	CcSEcCtD
Valrubicin—Anaemia—Cisplatin—peripheral nervous system neoplasm	8.86e-05	0.00258	CcSEcCtD
Valrubicin—Asthenia—Topotecan—peripheral nervous system neoplasm	8.76e-05	0.00255	CcSEcCtD
Valrubicin—Asthenia—Isotretinoin—peripheral nervous system neoplasm	8.69e-05	0.00253	CcSEcCtD
Valrubicin—Asthenia—Tretinoin—peripheral nervous system neoplasm	8.69e-05	0.00253	CcSEcCtD
Valrubicin—Malaise—Cisplatin—peripheral nervous system neoplasm	8.64e-05	0.00251	CcSEcCtD
Valrubicin—Pruritus—Topotecan—peripheral nervous system neoplasm	8.64e-05	0.00251	CcSEcCtD
Valrubicin—Asthenia—Melphalan—peripheral nervous system neoplasm	8.58e-05	0.0025	CcSEcCtD
Valrubicin—Pruritus—Tretinoin—peripheral nervous system neoplasm	8.57e-05	0.00249	CcSEcCtD
Valrubicin—Pruritus—Isotretinoin—peripheral nervous system neoplasm	8.57e-05	0.00249	CcSEcCtD
Valrubicin—Back pain—Etoposide—peripheral nervous system neoplasm	8.49e-05	0.00247	CcSEcCtD
Valrubicin—Pruritus—Melphalan—peripheral nervous system neoplasm	8.46e-05	0.00246	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	8.36e-05	0.00243	CcSEcCtD
Valrubicin—Diarrhoea—Topotecan—peripheral nervous system neoplasm	8.35e-05	0.00243	CcSEcCtD
Valrubicin—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	8.29e-05	0.00241	CcSEcCtD
Valrubicin—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	8.29e-05	0.00241	CcSEcCtD
Valrubicin—Diarrhoea—Melphalan—peripheral nervous system neoplasm	8.18e-05	0.00238	CcSEcCtD
Valrubicin—Myalgia—Cisplatin—peripheral nervous system neoplasm	8.16e-05	0.00237	CcSEcCtD
Valrubicin—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	8.16e-05	0.00237	CcSEcCtD
Valrubicin—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	8.15e-05	0.00237	CcSEcCtD
Valrubicin—Anaemia—Etoposide—peripheral nervous system neoplasm	8.11e-05	0.00236	CcSEcCtD
Valrubicin—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	8.09e-05	0.00236	CcSEcCtD
Valrubicin—Dizziness—Topotecan—peripheral nervous system neoplasm	8.07e-05	0.00235	CcSEcCtD
Valrubicin—Discomfort—Cisplatin—peripheral nervous system neoplasm	8.06e-05	0.00234	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	8.06e-05	0.00234	CcSEcCtD
Valrubicin—Dizziness—Isotretinoin—peripheral nervous system neoplasm	8.01e-05	0.00233	CcSEcCtD
Valrubicin—Dizziness—Tretinoin—peripheral nervous system neoplasm	8.01e-05	0.00233	CcSEcCtD
Valrubicin—Malaise—Etoposide—peripheral nervous system neoplasm	7.92e-05	0.0023	CcSEcCtD
Valrubicin—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	7.83e-05	0.00228	CcSEcCtD
Valrubicin—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	7.83e-05	0.00228	CcSEcCtD
Valrubicin—Doxorubicin—ABCB1—peripheral nervous system neoplasm	7.82e-05	0.0381	CrCbGaD
Valrubicin—Vomiting—Topotecan—peripheral nervous system neoplasm	7.76e-05	0.00226	CcSEcCtD
Valrubicin—Vomiting—Isotretinoin—peripheral nervous system neoplasm	7.7e-05	0.00224	CcSEcCtD
Valrubicin—Vomiting—Tretinoin—peripheral nervous system neoplasm	7.7e-05	0.00224	CcSEcCtD
Valrubicin—Rash—Topotecan—peripheral nervous system neoplasm	7.7e-05	0.00224	CcSEcCtD
Valrubicin—Dermatitis—Topotecan—peripheral nervous system neoplasm	7.69e-05	0.00224	CcSEcCtD
Valrubicin—Headache—Topotecan—peripheral nervous system neoplasm	7.65e-05	0.00223	CcSEcCtD
Valrubicin—Rash—Isotretinoin—peripheral nervous system neoplasm	7.64e-05	0.00222	CcSEcCtD
Valrubicin—Rash—Tretinoin—peripheral nervous system neoplasm	7.64e-05	0.00222	CcSEcCtD
Valrubicin—Dermatitis—Tretinoin—peripheral nervous system neoplasm	7.63e-05	0.00222	CcSEcCtD
Valrubicin—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	7.63e-05	0.00222	CcSEcCtD
Valrubicin—Vomiting—Melphalan—peripheral nervous system neoplasm	7.6e-05	0.00221	CcSEcCtD
Valrubicin—Headache—Tretinoin—peripheral nervous system neoplasm	7.59e-05	0.00221	CcSEcCtD
Valrubicin—Headache—Isotretinoin—peripheral nervous system neoplasm	7.59e-05	0.00221	CcSEcCtD
Valrubicin—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	7.56e-05	0.0022	CcSEcCtD
Valrubicin—Rash—Melphalan—peripheral nervous system neoplasm	7.54e-05	0.00219	CcSEcCtD
Valrubicin—Dermatitis—Melphalan—peripheral nervous system neoplasm	7.53e-05	0.00219	CcSEcCtD
Valrubicin—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	7.51e-05	0.00218	CcSEcCtD
Valrubicin—Chest pain—Etoposide—peripheral nervous system neoplasm	7.47e-05	0.00217	CcSEcCtD
Valrubicin—TOP2A—Daunorubicin—Epirubicin—peripheral nervous system neoplasm	7.4e-05	0.0476	CbGdCrCtD
Valrubicin—TOP2A—Doxorubicin—Epirubicin—peripheral nervous system neoplasm	7.4e-05	0.0476	CbGdCrCtD
Valrubicin—TOP2A—Idarubicin—Epirubicin—peripheral nervous system neoplasm	7.4e-05	0.0476	CbGdCrCtD
Valrubicin—Discomfort—Etoposide—peripheral nervous system neoplasm	7.38e-05	0.00215	CcSEcCtD
Valrubicin—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	7.26e-05	0.00211	CcSEcCtD
Valrubicin—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	7.26e-05	0.00211	CcSEcCtD
Valrubicin—Nausea—Topotecan—peripheral nervous system neoplasm	7.25e-05	0.00211	CcSEcCtD
Valrubicin—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	7.23e-05	0.0021	CcSEcCtD
Valrubicin—Nausea—Tretinoin—peripheral nervous system neoplasm	7.19e-05	0.00209	CcSEcCtD
Valrubicin—Nausea—Isotretinoin—peripheral nervous system neoplasm	7.19e-05	0.00209	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	7.12e-05	0.00207	CcSEcCtD
Valrubicin—Asthenia—Dactinomycin—peripheral nervous system neoplasm	7.1e-05	0.00207	CcSEcCtD
Valrubicin—Nausea—Melphalan—peripheral nervous system neoplasm	7.1e-05	0.00207	CcSEcCtD
Valrubicin—Body temperature increased—Vincristine—peripheral nervous system neoplasm	6.99e-05	0.00203	CcSEcCtD
Valrubicin—Abdominal pain—Vincristine—peripheral nervous system neoplasm	6.99e-05	0.00203	CcSEcCtD
Valrubicin—TOP2A—Epirubicin—Doxorubicin—peripheral nervous system neoplasm	6.84e-05	0.044	CbGdCrCtD
Valrubicin—TOP2A—Idarubicin—Doxorubicin—peripheral nervous system neoplasm	6.84e-05	0.044	CbGdCrCtD
Valrubicin—TOP2A—Daunorubicin—Doxorubicin—peripheral nervous system neoplasm	6.84e-05	0.044	CbGdCrCtD
Valrubicin—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	6.77e-05	0.00197	CcSEcCtD
Valrubicin—Dysuria—Epirubicin—peripheral nervous system neoplasm	6.6e-05	0.00192	CcSEcCtD
Valrubicin—Asthenia—Alitretinoin—peripheral nervous system neoplasm	6.59e-05	0.00192	CcSEcCtD
Valrubicin—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	6.52e-05	0.0019	CcSEcCtD
Valrubicin—Pruritus—Alitretinoin—peripheral nervous system neoplasm	6.49e-05	0.00189	CcSEcCtD
Valrubicin—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	6.44e-05	0.00187	CcSEcCtD
Valrubicin—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	6.37e-05	0.00185	CcSEcCtD
Valrubicin—Asthenia—Vincristine—peripheral nervous system neoplasm	6.35e-05	0.00185	CcSEcCtD
Valrubicin—Pneumonia—Epirubicin—peripheral nervous system neoplasm	6.33e-05	0.00184	CcSEcCtD
Valrubicin—Vomiting—Dactinomycin—peripheral nervous system neoplasm	6.29e-05	0.00183	CcSEcCtD
Valrubicin—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	6.28e-05	0.00183	CcSEcCtD
Valrubicin—Rash—Dactinomycin—peripheral nervous system neoplasm	6.24e-05	0.00182	CcSEcCtD
Valrubicin—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	6.18e-05	0.0018	CcSEcCtD
Valrubicin—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	6.12e-05	0.00178	CcSEcCtD
Valrubicin—Dysuria—Doxorubicin—peripheral nervous system neoplasm	6.11e-05	0.00178	CcSEcCtD
Valrubicin—Dizziness—Alitretinoin—peripheral nervous system neoplasm	6.07e-05	0.00177	CcSEcCtD
Valrubicin—Diarrhoea—Vincristine—peripheral nervous system neoplasm	6.05e-05	0.00176	CcSEcCtD
Valrubicin—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	6.04e-05	0.00176	CcSEcCtD
Valrubicin—Haematuria—Epirubicin—peripheral nervous system neoplasm	6e-05	0.00175	CcSEcCtD
Valrubicin—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	5.9e-05	0.00172	CcSEcCtD
Valrubicin—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	5.89e-05	0.00171	CcSEcCtD
Valrubicin—Nausea—Dactinomycin—peripheral nervous system neoplasm	5.88e-05	0.00171	CcSEcCtD
Valrubicin—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	5.86e-05	0.0017	CcSEcCtD
Valrubicin—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	5.86e-05	0.0017	CcSEcCtD
Valrubicin—Dizziness—Vincristine—peripheral nervous system neoplasm	5.85e-05	0.0017	CcSEcCtD
Valrubicin—Vomiting—Alitretinoin—peripheral nervous system neoplasm	5.84e-05	0.0017	CcSEcCtD
Valrubicin—Rash—Alitretinoin—peripheral nervous system neoplasm	5.79e-05	0.00168	CcSEcCtD
Valrubicin—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	5.78e-05	0.00168	CcSEcCtD
Valrubicin—Headache—Alitretinoin—peripheral nervous system neoplasm	5.75e-05	0.00167	CcSEcCtD
Valrubicin—Body temperature increased—Etoposide—peripheral nervous system neoplasm	5.66e-05	0.00165	CcSEcCtD
Valrubicin—Abdominal pain—Etoposide—peripheral nervous system neoplasm	5.66e-05	0.00165	CcSEcCtD
Valrubicin—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	5.66e-05	0.00165	CcSEcCtD
Valrubicin—Vomiting—Vincristine—peripheral nervous system neoplasm	5.62e-05	0.00164	CcSEcCtD
Valrubicin—Asthenia—Cisplatin—peripheral nervous system neoplasm	5.61e-05	0.00163	CcSEcCtD
Valrubicin—Rash—Vincristine—peripheral nervous system neoplasm	5.58e-05	0.00162	CcSEcCtD
Valrubicin—Dermatitis—Vincristine—peripheral nervous system neoplasm	5.57e-05	0.00162	CcSEcCtD
Valrubicin—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	5.57e-05	0.00162	CcSEcCtD
Valrubicin—Haematuria—Doxorubicin—peripheral nervous system neoplasm	5.56e-05	0.00162	CcSEcCtD
Valrubicin—Headache—Vincristine—peripheral nervous system neoplasm	5.54e-05	0.00161	CcSEcCtD
Valrubicin—Nausea—Alitretinoin—peripheral nervous system neoplasm	5.45e-05	0.00159	CcSEcCtD
Valrubicin—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	5.35e-05	0.00156	CcSEcCtD
Valrubicin—Nausea—Vincristine—peripheral nervous system neoplasm	5.25e-05	0.00153	CcSEcCtD
Valrubicin—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	5.15e-05	0.0015	CcSEcCtD
Valrubicin—Asthenia—Etoposide—peripheral nervous system neoplasm	5.14e-05	0.0015	CcSEcCtD
Valrubicin—Pruritus—Etoposide—peripheral nervous system neoplasm	5.07e-05	0.00147	CcSEcCtD
Valrubicin—Vomiting—Cisplatin—peripheral nervous system neoplasm	4.97e-05	0.00145	CcSEcCtD
Valrubicin—Rash—Cisplatin—peripheral nervous system neoplasm	4.93e-05	0.00143	CcSEcCtD
Valrubicin—Dermatitis—Cisplatin—peripheral nervous system neoplasm	4.93e-05	0.00143	CcSEcCtD
Valrubicin—Diarrhoea—Etoposide—peripheral nervous system neoplasm	4.9e-05	0.00143	CcSEcCtD
Valrubicin—Flatulence—Epirubicin—peripheral nervous system neoplasm	4.85e-05	0.00141	CcSEcCtD
Valrubicin—Back pain—Epirubicin—peripheral nervous system neoplasm	4.76e-05	0.00138	CcSEcCtD
Valrubicin—Dizziness—Etoposide—peripheral nervous system neoplasm	4.74e-05	0.00138	CcSEcCtD
Valrubicin—Nausea—Cisplatin—peripheral nervous system neoplasm	4.65e-05	0.00135	CcSEcCtD
Valrubicin—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	4.57e-05	0.00133	CcSEcCtD
Valrubicin—Vomiting—Etoposide—peripheral nervous system neoplasm	4.56e-05	0.00133	CcSEcCtD
Valrubicin—Anaemia—Epirubicin—peripheral nervous system neoplasm	4.55e-05	0.00132	CcSEcCtD
Valrubicin—Rash—Etoposide—peripheral nervous system neoplasm	4.52e-05	0.00131	CcSEcCtD
Valrubicin—Dermatitis—Etoposide—peripheral nervous system neoplasm	4.51e-05	0.00131	CcSEcCtD
Valrubicin—Headache—Etoposide—peripheral nervous system neoplasm	4.49e-05	0.00131	CcSEcCtD
Valrubicin—Flatulence—Doxorubicin—peripheral nervous system neoplasm	4.49e-05	0.00131	CcSEcCtD
Valrubicin—Malaise—Epirubicin—peripheral nervous system neoplasm	4.44e-05	0.00129	CcSEcCtD
Valrubicin—Back pain—Doxorubicin—peripheral nervous system neoplasm	4.4e-05	0.00128	CcSEcCtD
Valrubicin—Nausea—Etoposide—peripheral nervous system neoplasm	4.26e-05	0.00124	CcSEcCtD
Valrubicin—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	4.22e-05	0.00123	CcSEcCtD
Valrubicin—Anaemia—Doxorubicin—peripheral nervous system neoplasm	4.21e-05	0.00122	CcSEcCtD
Valrubicin—Myalgia—Epirubicin—peripheral nervous system neoplasm	4.19e-05	0.00122	CcSEcCtD
Valrubicin—Chest pain—Epirubicin—peripheral nervous system neoplasm	4.19e-05	0.00122	CcSEcCtD
Valrubicin—Discomfort—Epirubicin—peripheral nervous system neoplasm	4.14e-05	0.0012	CcSEcCtD
Valrubicin—Malaise—Doxorubicin—peripheral nervous system neoplasm	4.11e-05	0.00119	CcSEcCtD
Valrubicin—Chest pain—Doxorubicin—peripheral nervous system neoplasm	3.88e-05	0.00113	CcSEcCtD
Valrubicin—Myalgia—Doxorubicin—peripheral nervous system neoplasm	3.88e-05	0.00113	CcSEcCtD
Valrubicin—Discomfort—Doxorubicin—peripheral nervous system neoplasm	3.83e-05	0.00111	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	3.66e-05	0.00106	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	3.39e-05	0.000985	CcSEcCtD
Valrubicin—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	3.31e-05	0.000963	CcSEcCtD
Valrubicin—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	3.28e-05	0.000955	CcSEcCtD
Valrubicin—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	3.17e-05	0.000924	CcSEcCtD
Valrubicin—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	3.17e-05	0.000924	CcSEcCtD
Valrubicin—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	3.06e-05	0.000891	CcSEcCtD
Valrubicin—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	3.04e-05	0.000884	CcSEcCtD
Valrubicin—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	2.94e-05	0.000855	CcSEcCtD
Valrubicin—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	2.94e-05	0.000855	CcSEcCtD
Valrubicin—Asthenia—Epirubicin—peripheral nervous system neoplasm	2.88e-05	0.000838	CcSEcCtD
Valrubicin—Pruritus—Epirubicin—peripheral nervous system neoplasm	2.84e-05	0.000827	CcSEcCtD
Valrubicin—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	2.75e-05	0.000799	CcSEcCtD
Valrubicin—Asthenia—Doxorubicin—peripheral nervous system neoplasm	2.67e-05	0.000776	CcSEcCtD
Valrubicin—Dizziness—Epirubicin—peripheral nervous system neoplasm	2.66e-05	0.000773	CcSEcCtD
Valrubicin—Pruritus—Doxorubicin—peripheral nervous system neoplasm	2.63e-05	0.000765	CcSEcCtD
Valrubicin—Vomiting—Epirubicin—peripheral nervous system neoplasm	2.55e-05	0.000743	CcSEcCtD
Valrubicin—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	2.54e-05	0.00074	CcSEcCtD
Valrubicin—Rash—Epirubicin—peripheral nervous system neoplasm	2.53e-05	0.000737	CcSEcCtD
Valrubicin—Dermatitis—Epirubicin—peripheral nervous system neoplasm	2.53e-05	0.000736	CcSEcCtD
Valrubicin—Headache—Epirubicin—peripheral nervous system neoplasm	2.52e-05	0.000732	CcSEcCtD
Valrubicin—Dizziness—Doxorubicin—peripheral nervous system neoplasm	2.46e-05	0.000715	CcSEcCtD
Valrubicin—Nausea—Epirubicin—peripheral nervous system neoplasm	2.39e-05	0.000694	CcSEcCtD
Valrubicin—Vomiting—Doxorubicin—peripheral nervous system neoplasm	2.36e-05	0.000687	CcSEcCtD
Valrubicin—Rash—Doxorubicin—peripheral nervous system neoplasm	2.34e-05	0.000682	CcSEcCtD
Valrubicin—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	2.34e-05	0.000681	CcSEcCtD
Valrubicin—Headache—Doxorubicin—peripheral nervous system neoplasm	2.33e-05	0.000677	CcSEcCtD
Valrubicin—Nausea—Doxorubicin—peripheral nervous system neoplasm	2.21e-05	0.000642	CcSEcCtD
